Jane Street’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Jane Street’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-98,099	Closed	-$620K	–	10457
2022 Q4	$620K	Sell	98,099 -38,031	-28%	-$211K	﹤0.01%	5767
2022 Q3	$697K	Buy	+136,130	New	+$855K	﹤0.01%	6073
2019 Q3	–	Sell	-3,998	Closed	-$59K	–	5968
2019 Q2	$59K	Buy	+3,998	New	+$107K	﹤0.01%	4933

Jane Street's FSTX Position: Q1 2023 in Review

Jane Street sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 98,099 shares — an estimated $620K sold.

Jane Street first reported a position in FSTX in Q2 2019 and held it in 3 quarters. The position peaked at $697K in Q3 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Jane Street reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Jane Street sold 98,099 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $620K.
Jane Street first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
Jane Street's F-star Therapeutics, Inc. Common Stock position peaked at $697K in Q3 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.